NCT03112603 · Interventional trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Overall registry status Completed
Phase 3
Conditions Graft-versus-host Disease (GVHD)
Delaware Valley sites
- Incyte Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory